HYPERION DEFI, INC. Interest Expense Nonoperating
HYPERION DEFI, INC. (HYPD) reported Interest Expense Nonoperating of $233.76 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-13
- HYPERION DEFI, INC. interest expense nonoperating for the quarter ending 2026-06-30 was $233.76K, a 55.76% decline year-over-year.
- HYPERION DEFI, INC. interest expense nonoperating for the quarter ending 2026-03-31 was $225.87K, a 61.16% decline year-over-year.
- HYPERION DEFI, INC. interest expense nonoperating for the quarter ending 2025-12-31 was $224.80K, a 57.56% decline year-over-year.
- HYPERION DEFI, INC. interest expense nonoperating for the quarter ending 2025-09-30 was $223.08K, a 62.95% decline year-over-year.
- HYPERION DEFI, INC. interest expense nonoperating for fiscal 2025 was $1.56M, a 37.30% decline from fiscal 2024.
- HYPERION DEFI, INC. interest expense nonoperating for fiscal 2024 was $2.48M, a 4.75% increase from fiscal 2023.
- HYPERION DEFI, INC. interest expense nonoperating for fiscal 2023 was $2.37M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $233.76K 10-Q · filed 2026-08-13 | $459.63K 10-Q · filed 2026-08-13 | $684.43K derived: sum of 3 quarters · filed 2026-08-13 | $907.51K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $225.87K 10-Q · filed 2026-05-15 | $450.67K derived: sum of 2 quarters · filed 2026-05-15 | $673.75K derived: sum of 3 quarters · filed 2026-05-15 | $1.20M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $224.80K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $447.88K derived: sum of 2 quarters · filed 2026-03-30 | $976.29K derived: sum of 3 quarters · filed 2026-08-13 | $1.56M 10-K · filed 2026-03-30 |
| 2025-09-30 | $223.08K 10-Q · filed 2025-11-14 | $751.49K derived: sum of 2 quarters · filed 2026-08-13 | $1.33M 10-Q · filed 2025-11-14 | $1.86M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $528.41K 10-Q · filed 2026-08-13 | $1.11M 10-Q · filed 2026-08-13 | $1.64M derived: sum of 3 quarters · filed 2026-08-13 | $2.24M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $581.50K 10-Q · filed 2026-05-15 | $1.11M derived: sum of 2 quarters · filed 2026-05-15 | $1.71M derived: sum of 3 quarters · filed 2026-05-15 | $2.39M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $529.66K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.13M derived: sum of 2 quarters · filed 2026-03-30 | $1.81M derived: sum of 3 quarters · filed 2026-03-30 | $2.48M 10-K · filed 2026-03-30 |
| 2024-09-30 | $602.11K 10-Q · filed 2025-11-14 | $1.28M derived: sum of 2 quarters · filed 2025-11-14 | $1.95M 10-Q · filed 2025-11-14 | $2.64M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $674.00K 10-Q · filed 2025-08-13 | $1.35M 10-Q · filed 2025-08-13 | $2.03M derived: sum of 3 quarters · filed 2025-08-13 | $2.71M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $678.66K 10-Q · filed 2025-05-19 | $1.36M derived: sum of 2 quarters · filed 2025-05-19 | $2.04M derived: sum of 3 quarters · filed 2025-05-19 | $2.60M derived: sum of 4 quarters · filed 2025-05-19 |
| 2023-12-31 | $680.62K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $1.36M derived: sum of 2 quarters · filed 2025-04-15 | $1.92M derived: sum of 3 quarters · filed 2025-04-15 | $2.37M 10-K · filed 2025-04-15 |
| 2023-09-30 | $679.22K 10-Q · filed 2024-11-12 | $1.24M derived: sum of 2 quarters · filed 2024-11-12 | $1.69M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $558.00K 10-Q · filed 2024-08-14 | $1.01M 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |